Ross MacDonald
Corporate Officer/Principal at Licensing Executives Society of Australia & New Zealand
Net worth: 240 920 $ as of 2024-02-28
Profile
Ross Alexander MacDonald is Investment committee Member at Uniseed Management Pty Ltd.
He is also Member of Licensing Executives Society of Australia & New Zealand.
In his past career Dr. MacDonald held the position of Chief Executive Officer of Living Cell Technologies Ltd., Chief Executive Officer & Managing Director at Cynata Therapeutics Ltd., Non-Executive Director at Hatchtech Pty Ltd., Vice President-Corporate Development for Stiefel Laboratories, Inc. (New York), Managing Director at Stiefel Research Australia Pty Ltd., Vice President-Research & Development of FH Faulding & Co. Ltd., Vice President-Business Development of Connetics Corp.
and Vice President-Business Development at Sinclair Pharmaceuticals Ltd.
Ross Alexander MacDonald received a doctorate from Monash University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-08-03 | 2,000,000 ( 1.11% ) | 240 920 $ | 2024-02-28 |
Ross MacDonald active positions
Companies | Position | Start |
---|---|---|
Licensing Executives Society of Australia & New Zealand | Corporate Officer/Principal | - |
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Private Equity Investor | - |
Former positions of Ross MacDonald
Companies | Position | End |
---|---|---|
CYNATA THERAPEUTICS LIMITED | Chief Executive Officer | 2023-06-30 |
RESPIRI LIMITED | Director/Board Member | 2014-02-04 |
TELESSO TECHNOLOGIES LTD. | Director/Board Member | 2013-11-18 |
ALGORAE PHARMACEUTICALS LIMITED | Chief Executive Officer | 2011-06-23 |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Training of Ross MacDonald
Monash University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
RESPIRI LIMITED | Health Technology |
CYNATA THERAPEUTICS LIMITED | Health Technology |
Private companies | 10 |
---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Telesso Technologies Ltd.
Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Telesso Technologies Ltd. was engaged in biotechnology research and development. The company was founded on December 15, 1995 and was headquartered in Melbourne, Australia. | Health Technology |
FH Faulding & Co. Ltd. | Health Technology |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The private company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Finance |
Hatchtech Pty Ltd.
Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Health Technology |
Stiefel Laboratories, Inc. (New York)
Stiefel Laboratories, Inc. (New York) Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. (New York) develops, manufactures and markets products for the care and treatment of skin diseases. The company is headquartered in Oak Hill, NY. | Health Technology |
Sinclair Pharmaceuticals Ltd.
Sinclair Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1971, Sinclair Pharmaceuticals Ltd. is a subsidiary of Huadong Medicine Co., Ltd. that manufactures and distributes pharmaceutical products. The private company is based in Chester, UK. | Health Technology |
Licensing Executives Society of Australia & New Zealand | |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |